Intensified Insulin Therapy With Telemedicine

Randomized Controlled Clinical Trial of Telemedicine-guided Lifestyle Intervention in Diabetic Patients During Intensive Insulin Therapy.

Investigation of the effect of a 3-month telemedicine-led lifestyle intervention in individuals requiring intensified insulin therapy.

The primary objective of this study was to evaluate the development of HbA1c levels in patients requiring 3 months of intensified insulin therapy using standard therapy and telemedicine devices currently in use.

The telemedicine system contains a mobile phone-based nutrition diary, bluetooth-related wrist activity meter, weight scale, blood pressure monitor, blood glucose meter, and IT system for transmitting and displaying data from these devices.

Inclusion Criteria:

• Women or men between the ages of 18 and 75
• Patient with Diabetes who needs intensified insulin therapy HbA1c> = 8%
• IT proficiency is at least basic for cell phones (answering / making a voice call).
• Signing a informed consent
• For women with childbearing potential, by definition, all women who who are physiologically able to conceive are twofold use of contraception
• The subject communicates well with the investigator and is able to perform the test to understand and help comply with the requirements of the protocol

Exclusion Criteria:

• informed refusal any time after the sign of the informed consent
• Planned invasive cardiac intervention (catheter vasodilation or surgical coronary artery bypass grafting, keyboard surgery or replacement)
• Tumor disease
• Pregnant or lactating women
• Any medical condition that does not allow participation